TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Kubator Therapeutics AB
Closing information (x1000 EUR)
| Closing information | 2025/01 | 2024/01 | 2023/01 |
| Turnover |
222
|
233
|
260 |
| Financial expenses |
40
|
39
|
6 |
| Earnings before taxes |
74
|
127
|
154 |
| EBITDA |
108
|
154
|
150 |
| Total assets |
327
|
458
|
384 |
| Current assets |
223
|
314
|
230 |
| Current liabilities |
32
|
187
|
130 |
| Equity capital |
262
|
243
|
236 |
| - share capital |
4
|
4
|
4 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2025/01 | 2024/01 | 2023/01 |
| Solvency |
80.1%
|
53.1%
|
61.5% |
| Turnover per employee |
222
|
233
|
260 |
| Profit as a percentage of turnover |
33.3%
|
54.5%
|
59.2% |
| Return on assets (ROA) |
34.9%
|
36.2%
|
41.7% |
| Current ratio |
696.9%
|
167.9%
|
176.9% |
| Return on equity (ROE) |
28.2%
|
52.3%
|
65.3% |
| Change turnover |
-7
|
-27
|
48 |
| Change turnover % |
-3%
|
-10%
|
22% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/01 | 2024/01 | 2023/01 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.